GNLX
Price
$4.67
Change
-$0.06 (-1.27%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
186.45M
Intraday BUY SELL Signals
SNSE
Price
$8.70
Change
+$0.50 (+6.10%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
10.61M
Intraday BUY SELL Signals
Interact to see
Advertisement

GNLX vs SNSE

Header iconGNLX vs SNSE Comparison
Open Charts GNLX vs SNSEBanner chart's image
Genelux
Price$4.67
Change-$0.06 (-1.27%)
Volume$2.45K
Capitalization186.45M
Sensei Biotherapeutics
Price$8.70
Change+$0.50 (+6.10%)
Volume$100
Capitalization10.61M
GNLX vs SNSE Comparison Chart in %
GNLX
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNLX vs. SNSE commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Buy and SNSE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (GNLX: $4.73 vs. SNSE: $8.31)
Brand notoriety: GNLX and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 47% vs. SNSE: 19%
Market capitalization -- GNLX: $186.45M vs. SNSE: $10.61M
GNLX [@Biotechnology] is valued at $186.45M. SNSE’s [@Biotechnology] market capitalization is $10.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 6 TA indicator(s) are bullish while SNSE’s TA Score has 3 bullish TA indicator(s).

  • GNLX’s TA Score: 6 bullish, 4 bearish.
  • SNSE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than SNSE.

Price Growth

GNLX (@Biotechnology) experienced а -10.59% price change this week, while SNSE (@Biotechnology) price change was -3.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($186M) has a higher market cap than SNSE($10.6M). GNLX YTD gains are higher at: 100.424 vs. SNSE (-15.201). SNSE has higher annual earnings (EBITDA): -26.03M vs. GNLX (-29.74M). SNSE (28.6M) and GNLX (28M) have equal amount of cash in the bank . GNLX has less debt than SNSE: GNLX (1.71M) vs SNSE (2.56M). GNLX (0) and SNSE (0) have equivalent revenues.
GNLXSNSEGNLX / SNSE
Capitalization186M10.6M1,755%
EBITDA-29.74M-26.03M114%
Gain YTD100.424-15.201-661%
P/E RatioN/AN/A-
Revenue00-
Total Cash28M28.6M98%
Total Debt1.71M2.56M67%
TECHNICAL ANALYSIS
Technical Analysis
GNLXSNSE
RSI
ODDS (%)
Bullish Trend 6 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 6 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
81%
Aroon
ODDS (%)
Bullish Trend 6 days ago
88%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signal:
Gain/Loss:
SNSE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTGC18.360.28
+1.55%
Hercules Capital
STLD167.60-0.02
-0.01%
Steel Dynamics
OPY66.78-0.55
-0.82%
Oppenheimer Holdings
PAVM0.32-0.03
-8.47%
PAVmed
CTOR1.29-0.34
-21.04%
Citius Oncology Inc

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-3.47%
SYRE - GNLX
36%
Loosely correlated
-0.91%
XERS - GNLX
32%
Poorly correlated
-7.04%
SNSE - GNLX
32%
Poorly correlated
-1.17%
RXRX - GNLX
32%
Poorly correlated
-0.69%
ATYR - GNLX
32%
Poorly correlated
-4.02%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-1.17%
VSTM - SNSE
47%
Loosely correlated
-5.51%
ALZN - SNSE
40%
Loosely correlated
-1.91%
MOLN - SNSE
39%
Loosely correlated
+5.72%
INAB - SNSE
37%
Loosely correlated
-8.67%
GRI - SNSE
37%
Loosely correlated
-1.02%
More